1102 related articles for article (PubMed ID: 31898515)
1. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway.
Lou G; Chen L; Xia C; Wang W; Qi J; Li A; Zhao L; Chen Z; Zheng M; Liu Y
J Exp Clin Cancer Res; 2020 Jan; 39(1):4. PubMed ID: 31898515
[TBL] [Abstract][Full Text] [Related]
2. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.
Lou G; Song X; Yang F; Wu S; Wang J; Chen Z; Liu Y
J Hematol Oncol; 2015 Oct; 8():122. PubMed ID: 26514126
[TBL] [Abstract][Full Text] [Related]
3. Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma.
Zhang K; Shao CX; Zhu JD; Lv XL; Tu CY; Jiang C; Shang MJ
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32463473
[TBL] [Abstract][Full Text] [Related]
4. AMSC-derived exosomes alleviate lipopolysaccharide/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP/NLRP3 inflammasome activation in macrophages.
Liu Y; Lou G; Li A; Zhang T; Qi J; Ye D; Zheng M; Chen Z
EBioMedicine; 2018 Oct; 36():140-150. PubMed ID: 30197023
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cell-derived exosomes block malignant behaviors of hepatocellular carcinoma stem cells through a lncRNA C5orf66-AS1/microRNA-127-3p/DUSP1/ERK axis.
Gu H; Yan C; Wan H; Wu L; Liu J; Zhu Z; Gao D
Hum Cell; 2021 Nov; 34(6):1812-1829. PubMed ID: 34431063
[TBL] [Abstract][Full Text] [Related]
6. MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis.
Lou G; Yang Y; Liu F; Ye B; Chen Z; Zheng M; Liu Y
J Cell Mol Med; 2017 Nov; 21(11):2963-2973. PubMed ID: 28544786
[TBL] [Abstract][Full Text] [Related]
7. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.
Fornari F; Milazzo M; Chieco P; Negrini M; Calin GA; Grazi GL; Pollutri D; Croce CM; Bolondi L; Gramantieri L
Cancer Res; 2010 Jun; 70(12):5184-93. PubMed ID: 20501828
[TBL] [Abstract][Full Text] [Related]
8. Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2.
Yu L; Gui S; Liu Y; Qiu X; Zhang G; Zhang X; Pan J; Fan J; Qi S; Qiu B
Aging (Albany NY); 2019 Aug; 11(15):5300-5318. PubMed ID: 31386624
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of microRNA-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice.
Varshney A; Panda JJ; Singh AK; Yadav N; Bihari C; Biswas S; Sarin SK; Chauhan VS
Hepatology; 2018 Apr; 67(4):1392-1407. PubMed ID: 29108133
[TBL] [Abstract][Full Text] [Related]
10. miR-199a-3p inhibits cell proliferation and induces apoptosis by targeting YAP1, suppressing Jagged1-Notch signaling in human hepatocellular carcinoma.
Ren K; Li T; Zhang W; Ren J; Li Z; Wu G
J Biomed Sci; 2016 Nov; 23(1):79. PubMed ID: 27832779
[TBL] [Abstract][Full Text] [Related]
11. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.
Huang GH; Shan H; Li D; Zhou B; Pang PF
Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837
[TBL] [Abstract][Full Text] [Related]
12. miR-660-5p-loaded M2 macrophages-derived exosomes augment hepatocellular carcinoma development through regulating KLF3.
Tian B; Zhou L; Wang J; Yang P
Int Immunopharmacol; 2021 Dec; 101(Pt B):108157. PubMed ID: 34673296
[TBL] [Abstract][Full Text] [Related]
13. Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling.
Xie CF; Feng KL; Wang JN; Luo R; Fang CK; Zhang Y; Shen CP; Zhong C
J Ethnopharmacol; 2022 Aug; 294():115360. PubMed ID: 35568116
[TBL] [Abstract][Full Text] [Related]
14. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10.
Xu Y; Lai Y; Cao L; Li Y; Chen G; Chen L; Weng H; Chen T; Wang L; Ye Y
RNA Biol; 2021 Oct; 18(10):1408-1423. PubMed ID: 33206588
[TBL] [Abstract][Full Text] [Related]
15. Low‑intensity ultrasound enhances the antitumor effects of doxorubicin on hepatocellular carcinoma cells through the ROS‑miR‑21‑PTEN axis.
Xia C; Zeng H; Zheng Y
Mol Med Rep; 2020 Mar; 21(3):989-998. PubMed ID: 32016465
[TBL] [Abstract][Full Text] [Related]
16. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.
Jin F; Wang Y; Li M; Zhu Y; Liang H; Wang C; Wang F; Zhang CY; Zen K; Li L
Cell Death Dis; 2017 Jan; 8(1):e2540. PubMed ID: 28079894
[TBL] [Abstract][Full Text] [Related]
17. miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines.
Henry JC; Park JK; Jiang J; Kim JH; Nagorney DM; Roberts LR; Banerjee S; Schmittgen TD
Biochem Biophys Res Commun; 2010 Dec; 403(1):120-5. PubMed ID: 21055388
[TBL] [Abstract][Full Text] [Related]
18. Silence of lncRNA HEIH suppressed liver cancer cell growth and metastasis through miR-199a-3p/mTOR axis.
Ma Y; Cao D; Li G; Hu J; Liu X; Liu J
J Cell Biochem; 2019 Oct; 120(10):17757-17766. PubMed ID: 31144384
[TBL] [Abstract][Full Text] [Related]
19. Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151.
Kim JH; Badawi M; Park JK; Jiang J; Mo X; Roberts LR; Schmittgen TD
Int J Oncol; 2016 Nov; 49(5):2037-2045. PubMed ID: 27599545
[TBL] [Abstract][Full Text] [Related]
20. The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming.
Liu Y; Ren H; Zhou Y; Shang L; Zhang Y; Yang F; Shi X
J Exp Clin Cancer Res; 2019 May; 38(1):228. PubMed ID: 31142342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]